-
公开(公告)号:US20100113547A1
公开(公告)日:2010-05-06
申请号:US12557368
申请日:2009-09-10
申请人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
发明人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
IPC分类号: A61K31/4166 , C07D233/40 , A61P35/00 , A61P19/10 , A61P15/00
CPC分类号: C07D233/60 , C07D233/66
摘要: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
摘要翻译: 公开了具有由下式表示的式的新化合物:其中X,R1,R2a,R2b,R2c,R3a R3b,R4a,R4b,R4c和m1如本文所述。 化合物可以制备成药物组合物,并且可以用于预防和治疗包括人在内的哺乳动物中的各种病症,包括非限制性实例,恶病质,骨质疏松症,肌肉减少症,性欲下降和/或 性功能障碍。
-
公开(公告)号:US20120178718A1
公开(公告)日:2012-07-12
申请号:US13167682
申请日:2011-06-23
申请人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
发明人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
IPC分类号: A61K31/4166 , A61K31/675 , A61P15/00 , A61P21/00 , A61P19/10 , A61P3/00
CPC分类号: C07D233/60 , C07D233/66
摘要: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3aR3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
摘要翻译: 公开了具有由下式表示的式的新化合物:其中X,R 1,R 2a,R 2b,R 2c,R 3aaR 3b,R 4a,R 4b,R 4c和m 1如本文所述。 化合物可以制备成药物组合物,并且可以用于预防和治疗包括人在内的哺乳动物中的各种病症,包括非限制性实例,恶病质,骨质疏松症,肌肉减少症,性欲下降和/或 性功能障碍。
-
公开(公告)号:US08383608B2
公开(公告)日:2013-02-26
申请号:US13167682
申请日:2011-06-23
申请人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
发明人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
IPC分类号: A61K31/4166 , A61K31/675 , A61P15/00
CPC分类号: C07D233/60 , C07D233/66
摘要: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
摘要翻译: 公开了具有由下式表示的式的新化合物:其中X,R1,R2a,R2b,R2c,R3a R3b,R4a,R4b,R4c和m1如本文所述。 化合物可以制备成药物组合物,并且可以用于预防和治疗包括人在内的哺乳动物中的各种病症,包括非限制性实例,恶病质,骨质疏松症,肌肉减少症,性欲下降和/或 性功能障碍。
-
公开(公告)号:US07968581B2
公开(公告)日:2011-06-28
申请号:US12557368
申请日:2009-09-10
申请人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
发明人: François Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanqué , Jean-Michel Lefrançois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Bert Paul Wigerinck
IPC分类号: A61K31/4166 , C07D233/40 , A61P35/00
CPC分类号: C07D233/60 , C07D233/66
摘要: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
摘要翻译: 公开了具有由下式表示的式的新化合物:其中X,R1,R2a,R2b,R2c,R3a R3b,R4a,R4b,R4c和m1如本文所述。 化合物可以制备成药物组合物,并且可以用于预防和治疗包括人在内的哺乳动物中的各种病症,包括非限制性实例,恶病质,骨质疏松症,肌肉减少症,性欲下降和/或 性功能障碍。
-
公开(公告)号:US20160250188A1
公开(公告)日:2016-09-01
申请号:US15031139
申请日:2014-10-24
申请人: Ernest D. Bush , Francois Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanque , Jean-Michel Lefrancois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Burt Paul Wigerinck
发明人: Ernest D. Bush , Francois Nique , Catherine Jagerschmidt , Florence Sylvie Namour , Roland Blanque , Jean-Michel Lefrancois , Christophe Peixoto , Pierre Deprez , Nicolas Triballeau , Piet Tom Burt Paul Wigerinck
IPC分类号: A61K31/4166 , A61K9/00
CPC分类号: A61K31/4166 , A61K9/0053
摘要: The present invention relates to, inter alia, treatment of muscle dystrophy (e.g., Duchenne Muscular Dystrophy), for example, using a composition, e.g., a composition comprising Compound (I), or a pharmaceutically acceptable salt, prodrug or metabolite thereof.
摘要翻译: 本发明尤其涉及治疗肌营养不良症(例如,Duchenne Muscular Dystrophy),例如,使用组合物,例如包含化合物(I)的组合物或其药学上可接受的盐,前药或代谢物。
-
-
-
-